Page 12 - 麻醉与监护论坛2015年第12期
P. 12

Laboratory and Clinical Investigation

the bag to ventilate. About three to four minutes when the      contents, and improves oxygenation[13].
Narcotrend index decreased to 60 and SpO2 maintained 98%;
orotracheal intubation with an endotracheal tube (internal           Because of the patient’s super obesity, small mouth,
diameter, 7.5mm) was performed. It is too hard to use the
visible laryngoscope to insert his small mouth. With the help   and Mallampati classification III, difficult intubation was
of another anesthesiologist and appropriate adjustment, we      suspected[14].
enter into his mouth. But the large tongue body obstructed
our scope, glottis exposure failed at first. During the second       Therefore, we prepared all the devices for difficult
attempt, we could see the glottis in the screen and then
intubated successfully. After intubation, propofol and          intubation in our operating room. We first tried intubation
remifentanil was administrated respectively 2μg/ml and
0.2μg/(kg.min). And 4%sevoflurane was added to reach the        with shikani optical stylet but glottis exposure failed
required anesthesia depth that narctrend maintained between
50 and 40. The infusion rate of cisatracurium was 0.2μg/(kg.    because of his small mouth and large tongue body. Then,
min) to provide sufficient muscle relaxation. Ventilation was
performed to keep end-tidal carbon dioxide partial pressure     intubation was successful after appropriate adjustment while
between 35 and 45 mmHg. Tidal volume was administrated
at 650ml, respiratory rate at 13 breaths/min and positive end-  Cormack and Lehane classification was Ⅲ. Neither obesity
expiratory pressure at 5 cmH2O. Circulation and respiratory
function monitored stably during the operation.                 nor BMI predicted difficult intubation, whereas the high

     The patient was sent to Post-anesthesia Care Unit (PACU)   Mallampati classification increased the potential for difficult
after the surgery completed successfully. The anesthesia        laryngoscopy and intubation[15]. This patient recovery from
recovery period was longer than other normal patients,
which could due to much fat influence pharmacokinetics          the anesthesia about 20 minutes, which longer than 10 to 12
of the anesthetics. We used atropine 1mg, neostigmine 2mg
and aminophylline 125mg to antagonize the residual muscle       minutes of normal patients. Considering this patient has no
relaxant. After extubation, SpO2 maintained 98%, respiratory
rate 18 breathes/min, pulses 80 bpm and blood pressure          coexisting disease and sufficient preparation, we successfully
135/85 mmHg, he was conscious and sent back to sickroom.
Interview followed the surgery after 24 hours, no nausea and    treated a 126kg female patient for inguinal herniorrhaphy by
vomiting, no urine retention and no headache were found.
Verbal Rating Scale tested 1 point with mild pain.              general anesthesia with propofol and remifentanil, pressure-

   Discussion                                                   controlled ventilation.

     Anesthesia for such obese patients has many problems,      REFERENCES
especially in airway management, intubation choice,             [1] Conway, B. and A. Rene, Obesity as a disease: no lightweight
dose of anesthetics and postoperative analgesia. The
pathophysiologic changes in obese patients would decrease               matter. Obesity Reviews, 2004. 5(3): p. 145-151.
lung volume and capacity along with BMI increasing,             [2] Katzmarzyk, P., I. Janssen, and C. Ardern, Physical inactivity, excess
while increase the oxygen consumption, carbon dioxide
production and work of breathing. Preoperative evaluation               adiposity and premature mortality. Obesity Reviews, 2003. 4(4): p. 257-290.
must make the global assessment, and also should be toward      [3] Adams, J. and P. Murphy, Obesity in anaesthesia and intensive care.
the coexisting diseases. Sufficient preoperative evaluation
lays a solid foundation of the surgery success. Some                    British journal of anaesthesia, 2000. 85(1): p. 91-108.
experts recommend that anesthesia induction of morbidly         [4] Després, J.-P., I. Lemieux, and D. Prud'homme, Treatment
obese patients in a 30° head-up position could improve
laryngoscopic view, increase well-tolerated apneic time                 of obesity: need to focus on high risk abdominally obese patients.
by relieving pressure on the diaphragm from abdominal                   BMJ: British Medical Journal, 2001. 322(7288): p. 716.
                                                                [5] Kopelman, P., Health risks associated with overweight and obesity.
                                                                        Obesity Reviews, 2007. 8: p. 13-17.
                                                                [6] Scopinaro, N., et al., Long-term control of type 2 diabetes
                                                                        mellitus and the other major components of the metabolic syndrome
                                                                        after biliopancreatic diversion in patients with BMI<35kg/m2.
                                                                        Obesity surgery, 2007. 17(2): p. 185-192.
                                                                [7] Valera-Mora, M.E., et al., Predictors of weight loss and reversal of
                                                                        comorbidities in malabsorptive bariatric surgery. The American
                                                                        journal of clinical nutrition, 2005. 81(6): p. 1292-1297.
                                                                [8] Voyagis, G., et al., Value of oropharyngeal Mallampati classification
                                                                        in predicting difficult laryngoscopy among obese patients. European
                                                                        journal of anaesthesiology, 1998. 15(3): p. 330-334.
                                                                [9] Benumof, J.L., Obstructive sleep apnea in the adult obese patient:
                                                                        implications for airway management. Journal of clinical anesthesia,
                                                                        2001. 13(2): p. 144-156.
                                                                [10] Wilson, M., et al., Predicting difficult intubation. British journal of
                                                                        anaesthesia, 1988. 61(2): p. 211-216.
                                                                [11] Blouin, R., J. Kolpek, and H. Mann, Influence of obesity on drug
                                                                        disposition. Clinical pharmacy, 1987. 6(9): p. 706.
                                                                [12] Backman, L., et al., Cardiovascular function in extreme obesity.
                                                                        Acta Medica Scandinavica, 1973. 193(1-6): p. 437-446.
                                                                [13] Sinha, A.C., Some anesthetic aspects of morbid obesity. Current
                                                                        Opinion in Anesthesiology, 2009. 22(3): p. 442-446.
                                                                [14] El-Ganzouri, A.R., et al., Preoperative airway assessment:
                                                                        predictive value of a multivariate risk index. Anesthesia & Analgesia,
                                                                       1996. 82(6): p. 1197-1204.
                                                                [15] Brodsky, J.B., et al., Morbid obesity and tracheal intubation.
                                                                        Anesthesia & Analgesia, 2002. 94(3): p. 732-736.

Laboratory and Clinical Investigation  120                      FAM 2013 Mar/Apr Vol.20 Issue 2
                                       123
   7   8   9   10   11   12   13   14   15   16   17